These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19020639)

  • 1. Effect of bimatoprost on intraocular pressure after cataract surgery.
    Unal M; Yücel I
    Can J Ophthalmol; 2008 Dec; 43(6):712-6. PubMed ID: 19020639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bimatoprost on intraocular pressure after phacoemulsification in eyes with exfoliation syndrome.
    Takmaz T; Can I; Gürdal C; Kürkçüoğlu P; Aşik S
    Acta Ophthalmol Scand; 2007 May; 85(3):262-6. PubMed ID: 17488454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
    Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
    Artunay O; Yuzbasioglu E; Unal M; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):513-7. PubMed ID: 20874499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
    Cetinkaya A; Akman A; Akova YA
    J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification.
    Kir E; Cakmak H; Dayanir V
    Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
    Borazan M; Karalezli A; Akman A; Akova YA
    J Cataract Refract Surg; 2007 Nov; 33(11):1941-5. PubMed ID: 17964402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification.
    Katsimpris JM; Siganos D; Konstas AG; Kozobolis V; Georgiadis N
    J Cataract Refract Surg; 2003 Dec; 29(12):2288-94. PubMed ID: 14709288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brinzolamide-timolol fixed combination for the prevention of intraocular pressure elevation after phacoemulsification.
    Georgakopoulos CD; Makri OE; Plotas P; Pharmakakis N
    Clin Exp Ophthalmol; 2013; 41(7):662-7. PubMed ID: 23432730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of brimonidine in preventing intraocular pressure spikes following phacoemulsification in glaucoma patients.
    Kandarakis A; Soumplis V; Karampelas M; Panos C; Kyriakos N; Baxevanakis A; Karagiannis D
    Eur J Ophthalmol; 2010; 20(6):994-9. PubMed ID: 20544673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
    Ulaş F; Balbaba M; Çelebi S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):658-62. PubMed ID: 23461283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
    Katz LJ; Cohen JS; Batoosingh AL; Felix C; Shu V; Schiffman RM
    Am J Ophthalmol; 2010 Apr; 149(4):661-671.e1. PubMed ID: 20346780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracameral acetylcholine on latanoprost in preventing ocular hypertension after phacoemulsification and intraocular lens implantation.
    Lai JS; Chua JK; Loo A; Ho SY; Lam DS
    J Cataract Refract Surg; 2001 May; 27(5):700-5. PubMed ID: 11377899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.
    Macky TA
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):605-10. PubMed ID: 21034177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine.
    Kasetti SR; Desai SP; Sivakumar S; Sunderraj P
    J Cataract Refract Surg; 2002 Dec; 28(12):2177-80. PubMed ID: 12498856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.
    Day DG; Walters TR; Schwartz GF; Mundorf TK; Liu C; Schiffman RM; Bejanian M
    Br J Ophthalmol; 2013 Aug; 97(8):989-93. PubMed ID: 23743437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.